DGCI

The drug is developed by MSD and Ridgeback Biotherapeutics. A full treatment of Molnupiravir, an antiviral drug approved by the Drug Controller General of India for emergency use, will likely cost between Rs 2,000 and Rs 3,000. The…

Serum Stops COVID-19 Vaccine Trial In India; Russia Rolls Out Vaccine For Public Serum Institute of India (SII) paused the trials of Covishield, Oxford University-AstraZeneca’s COVID-19 vaccine after a notice issued the Drug Controller…